Q2 2013 Holdings
Filed 2013-08-14 | 92 holdings | $63.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Idec Inc(BIIB) | COM | 09062X103 | $49.8M | 231,282 | 77.9% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $13.2M | 726,629 | 20.6% |
| Aegerion Pharmaceuticals Inc | COM | 00767E102 | $226.3K | 3,573,426 | 0.4% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $103.5K | 2,722,088 | 0.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $68.0K | 5,081,717 | 0.1% |
| Ishares TR(IBB)Put | NASDQ BIO INDX | 464287556 | $46.8K | $269,400 | 0.1% |
| Acelrx Pharmaceuticals Inc(ACRXUSD) | COM | 00444T100 | $46.4K | 5,008,400 | 0.1% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $40.4K | 788,360 | 0.1% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $31.3K | 139,310 | 0.0% |
| Tesaro Inc | COM | 881569107 | $30.1K | 920,494 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $22.9K | 1,649,558 | 0.0% |
| Capital SR Living Corp | COM | 140475104 | $21.3K | 891,408 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $20.5K | 256,547 | 0.0% |
| Neptune Technologies Bioreso | COM | 64077P108 | $17.6K | 5,422,920 | 0.0% |
| Sarepta Therapeutics Inc(SRPT)Put | COM | 803607100 | $15.0K | $393,000 | 0.0% |
| Stemline Therapeutics Inc | COM | 85858C107 | $14.1K | 591,650 | 0.0% |
| Synta Pharmaceuticals Corp | COM | 87162T206 | $13.4K | 2,693,236 | 0.0% |
| Santarus Inc | COM | 802817304 | $13.2K | 625,000 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $11.3K | 96,256 | 0.0% |
| HCA Holdings Inc(HCA) | COM | 40412C101 | $11.1K | 308,560 | 0.0% |
| Chelsea Therapeutics Intl LT | COM | 163428105 | $10.7K | 4,658,680 | 0.0% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $10.5K | $275,000 | 0.0% |
| Salix Pharmaceuticals Inc | COM | 795435106 | $9.8K | 148,250 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $9.4K | 140,827 | 0.0% |
| NPS Pharmaceuticals Inc | COM | 62936P103 | $8.5K | 562,400 | 0.0% |
| Shire PLC | SPONSORED ADR | 82481R106 | $7.7K | 80,800 | 0.0% |
| Optimer Pharmaceuticals IncPut | COM | 68401H104 | $7.2K | $496,500 | 0.0% |
| Aetna Inc New | COM | 00817Y108 | $7.2K | 112,825 | 0.0% |
| Elan PLC | ADR | 284131208 | $6.8K | 483,000 | 0.0% |
| Astex Pharmaceuticals Inc | COM | 04624B103 | $6.8K | 1,649,423 | 0.0% |
| Spectranetics Corp | COM | 84760C107 | $6.3K | 337,797 | 0.0% |
| Dyax Corp | COM | 26746E103 | $6.0K | 1,722,502 | 0.0% |
| Athersys Inc(ATHXEUR) | COM | 04744L106 | $5.8K | 3,479,206 | 0.0% |
| Curis Inc | COM | 231269101 | $4.4K | 1,392,564 | 0.0% |
| Kamada LTD(KMDA) | SHS | M6240T109 | $4.4K | 394,860 | 0.0% |
| Covidien PLC | SHS | G2554F113 | $4.2K | 67,500 | 0.0% |
| Sequenom Inc | COM NEW | 817337405 | $4.1K | 985,180 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $4.0K | 739,144 | 0.0% |
| Neurocrine Biosciences Inc(NBIX)Put | COM | 64125C109 | $4.0K | $300,000 | 0.0% |
| Repros Therapeutics Inc | COM NEW | 76028H209 | $3.3K | 181,430 | 0.0% |
| Anacor Pharmaceuticals Inc | COM | 032420101 | $3.3K | 582,835 | 0.0% |
| Arena Pharmaceuticals IncPut | COM | 040047102 | $3.0K | $393,200 | 0.0% |
| Intermune Inc | COM | 45884X103 | $2.9K | 300,000 | 0.0% |
| Gilead Sciences Inc(GILD)Put | COM | 375558103 | $2.5K | $48,300 | 0.0% |
| Questcor Pharmaceuticals IncCall | COM | 74835Y101 | $2.3K | $50,000 | 0.0% |
| Champions Oncology Inc Rstd | COM | 15870P109 | $2.0K | 1,808,244 | 0.0% |
| Biodelivery Sciences Intl in(BDSIUSD) | COM | 09060J106 | $1.9K | 477,600 | 0.0% |
| Questcor Pharmaceuticals Inc | COM | 74835Y101 | $1.9K | 42,186 | 0.0% |
| Neostem Inc | COM NEW | 640650305 | $1.8K | 3,315,938 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $1.8K | 111,940 | 0.0% |